@godlessgardener's testosterone advice needs context

What did @godlessgardener actually say?

The creator documented a routine TRT follow-up visit and described using a topical testosterone cream applied to thin-skin areas like armpits and shoulders. He said low testosterone caused him fatigue, depression, decreased libido, and measurable bone loss in his spine confirmed by x-ray. He also made a claim worth flagging: that if TRT stops working, "you can always just quit" without tapering.

He was refreshingly candid about adjusting his own dose, going from the prescribed four clicks down to two, trying three, getting irritable, then settling back at two. That kind of self-experimentation is common. It's also something his doctor should probably know about.

Does the science back this up?

Most of what he describes aligns reasonably well with what the clinical literature says about hypogonadism. The symptoms he listed, including fatigue, depression, muscle loss, and reduced libido, are among the most consistently documented effects of low testosterone in men over 40.

On bone loss specifically, he's on solid ground. Testosterone plays a direct role in bone mineral density through its conversion to estradiol, which is the primary driver of bone resorption suppression in men. Tracz et al. (2006, Journal of Clinical Endocrinology and Metabolism) found that hypogonadal men showed measurable improvements in lumbar spine bone density after testosterone therapy. The connection between low T and spinal bone loss he described is clinically plausible and supported by evidence.

Topical testosterone gels and creams are also well-studied delivery methods. A 2019 review by Ramasamy et al. in Sexual Medicine Reviews confirmed that transdermal testosterone produces steady serum levels and is a legitimate clinical alternative to injections and pellets for many patients.

What did they get wrong (or right)?

The claim that stopping TRT is like stopping nothing, that you can "just quit," is where this video runs into trouble. That's not accurate for most men on long-term therapy. Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal axis. When you stop, your body's natural production doesn't simply resume immediately. Recovery time varies, and some men experience a period of low testosterone that's worse than their baseline. Bhasin et al. (2010, New England Journal of Medicine) documented HPG axis suppression as a predictable consequence of exogenous androgen use.

He also casually self-adjusted his dose without mentioning any follow-up bloodwork to see what his serum levels actually were at two versus four clicks. Dose titration in TRT should be guided by labs, not just mood and irritability levels, though his symptom tracking was at least self-aware.

Where he deserves credit: normalizing help-seeking for men with hormonal symptoms is genuinely useful. The stigma he describes is real and documented. Diaz et al. (2021, American Journal of Men's Health) found that masculine norms significantly delayed men seeking care for hypogonadism symptoms.

What should you actually know?

If you're a man over 40 experiencing the symptoms he described, getting your testosterone levels checked is a reasonable thing to do. But the diagnostic bar matters. A single morning total testosterone measurement below 300 ng/dL on two separate occasions is the generally accepted clinical threshold, per Endocrine Society guidelines (Bhasin et al., 2018). Some men are symptomatic at levels others tolerate fine, which is why symptom correlation alongside labs is standard practice.

On the delivery method question, topical testosterone is a legitimate option, but transfer risk to partners and children is a real consideration that he didn't mention. The FDA issued a black box warning on testosterone gels specifically because of documented cases of unintentional exposure in children. Application to covered areas like armpits reduces but does not eliminate this risk.

And on stopping TRT: if you've been on it for months or years, do not just quit. Talk to the prescribing provider about a supervised taper or monitoring protocol. The casual framing here could give someone the wrong impression about a decision that warrants medical guidance.

• Low testosterone is a clinical diagnosis requiring lab confirmation, not just symptom reporting alone.
• Bone mineral density loss is a documented consequence of hypogonadism in men.
• Topical testosterone is a valid delivery method but carries transfer risk that requires precautions.
• Self-adjusting TRT doses without lab monitoring is a common but potentially problematic practice.
• Stopping long-term TRT without medical guidance can cause a temporary but significant hormonal crash.